image oligomannate alzheimers drug china

China’s new Alzheimer drug greeted with ‘surprise and skepticism’ by researchers

Emily Makowski | 
China’s approval of the drug oligomannate earlier this month for treating mild to moderate Alzheimer’s disease has been met with surprise and ...
b ef a a d b c a

China’s new seaweed-based Alzheimer’s therapy raises hopes—and questions about safety, effectiveness

Andrew Joseph | 
Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, potentially shaking up the field ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists